These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 19631411

  • 1. [The value of MELD in the allocation of priority for liver transplantation candidates].
    Colmenero J, Castro-Narro G, Navasa M.
    Gastroenterol Hepatol; 2010 Apr; 33(4):330-6. PubMed ID: 19631411
    [Abstract] [Full Text] [Related]

  • 2. Predictors of death on the waiting list for liver transplantation characterized by a long waiting time.
    Gheorghe L, Popescu I, Iacob R, Iacob S, Gheorghe C.
    Transpl Int; 2005 May; 18(5):572-6. PubMed ID: 15819806
    [Abstract] [Full Text] [Related]

  • 3. Liver transplantation for hepatocellular carcinoma: the MELD impact.
    Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H, Byrne T, Vargas HE, Mulligan D, Rakela J, Wiesner RH.
    Liver Transpl; 2004 Jan; 10(1):36-41. PubMed ID: 14755775
    [Abstract] [Full Text] [Related]

  • 4. Application of a continuous disease severity score to the OPTN liver waiting list.
    Edwards EB, Harper AM.
    Clin Transpl; 2001 Jan; ():19-24. PubMed ID: 12211782
    [Abstract] [Full Text] [Related]

  • 5. Model for end-stage liver disease (MELD) and allocation of donor livers.
    Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, Lake J, Howard T, Merion RM, Wolfe RA, Krom R, United Network for Organ Sharing Liver Disease Severity Score Committee.
    Gastroenterology; 2003 Jan; 124(1):91-6. PubMed ID: 12512033
    [Abstract] [Full Text] [Related]

  • 6. The MELD score in patients awaiting liver transplant: strengths and weaknesses.
    Bernardi M, Gitto S, Biselli M.
    J Hepatol; 2011 Jun; 54(6):1297-306. PubMed ID: 21145851
    [Abstract] [Full Text] [Related]

  • 7. Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.
    Tenório AL, Macedo FI, Miranda LE, Fernandes JL, da Silva CM, Neto OL, Lacerda CM.
    Transplant Proc; 2010 Mar; 42(2):407-11. PubMed ID: 20304152
    [Abstract] [Full Text] [Related]

  • 8. Selection of candidates with HCC for transplantation in the MELD era.
    Sala M, Varela M, Bruix J.
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S4-9. PubMed ID: 15382217
    [Abstract] [Full Text] [Related]

  • 9. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM, ESLD-HIV Working Group Investigators.
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [Abstract] [Full Text] [Related]

  • 10. The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics.
    Weismüller TJ, Negm A, Becker T, Barg-Hock H, Klempnauer J, Manns MP, Strassburg CP.
    Transpl Int; 2009 Oct; 22(10):970-8. PubMed ID: 19619170
    [Abstract] [Full Text] [Related]

  • 11. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O, Perrella A, Arenga G.
    Transplant Proc; 2008 Oct; 40(6):1906-9. PubMed ID: 18675085
    [Abstract] [Full Text] [Related]

  • 12. Survival before and after model for end-stage liver disease score introduction on the Brazilian liver transplant waiting list.
    Castro RS, Deisanti D, Seva-Pereira T, Almeida JR, Yamanaka A, Boin IF, Soares EC.
    Transplant Proc; 2010 Mar; 42(2):412-6. PubMed ID: 20304153
    [Abstract] [Full Text] [Related]

  • 13. Liver transplant recipient selection: MELD vs. clinical judgment.
    Fink MA, Angus PW, Gow PJ, Berry SR, Wang BZ, Muralidharan V, Christophi C, Jones RM.
    Liver Transpl; 2005 Jun; 11(6):621-6. PubMed ID: 15915491
    [Abstract] [Full Text] [Related]

  • 14. Model for end-stage liver disease score-based allocation of donors for liver transplantation: a spanish multicenter experience.
    de la Mata M, Cuende N, Huet J, Bernardos A, Ferrón JA, Santoyo J, Pascasio JM, Rodrigo J, Solórzano G, Martín-Vivaldi R, Alonso M.
    Transplantation; 2006 Dec 15; 82(11):1429-35. PubMed ID: 17164713
    [Abstract] [Full Text] [Related]

  • 15. Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease-sodium scores determined at three university-based laboratories of the same area.
    Xiol X, Gines P, Castells L, Twose J, Ribalta A, Fuentes-Arderiu X, Rodriguez S, Castellote J, Navasa M, Deulofeu R.
    Liver Transpl; 2009 Mar 15; 15(3):300-5. PubMed ID: 19242993
    [Abstract] [Full Text] [Related]

  • 16. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival.
    Ioannou GN, Perkins JD, Carithers RL.
    Gastroenterology; 2008 May 15; 134(5):1342-51. PubMed ID: 18471511
    [Abstract] [Full Text] [Related]

  • 17. MELD-XI: a rational approach to "sickest first" liver transplantation in cirrhotic patients requiring anticoagulant therapy.
    Heuman DM, Mihas AA, Habib A, Gilles HS, Stravitz RT, Sanyal AJ, Fisher RA.
    Liver Transpl; 2007 Jan 15; 13(1):30-7. PubMed ID: 17154400
    [Abstract] [Full Text] [Related]

  • 18. MELD-based liver allocation: who is underserved?
    Biggins SW, Bambha K.
    Semin Liver Dis; 2006 Aug 15; 26(3):211-20. PubMed ID: 16850370
    [Abstract] [Full Text] [Related]

  • 19. Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality?
    Austin MT, Poulose BK, Ray WA, Arbogast PG, Feurer ID, Pinson CW.
    Arch Surg; 2007 Nov 15; 142(11):1079-85. PubMed ID: 18025337
    [Abstract] [Full Text] [Related]

  • 20. Model for end-stage liver disease: impact of the new deceased donor liver allocation policy in São Paulo, Brazil.
    Monteiro F, Coria SA, Boni R, Pereira LA.
    Transplant Proc; 2009 Nov 15; 41(1):226-8. PubMed ID: 19249520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.